当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Tacrolimus
HUMAN COMPOUNDED DRUG
79926-010
Wedgewood Connect, LLC
2021/2/1 0:00:00
TACROLIMUS
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
79926-010-01
Cyclosporine
HUMAN COMPOUNDED DRUG
79926-002
Wedgewood Connect, LLC
2021/2/1 0:00:00
CYCLOSPORINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
79926-002-01
Cyclosporine
HUMAN COMPOUNDED DRUG
79926-003
Wedgewood Connect, LLC
2021/2/1 0:00:00
CYCLOSPORINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
79926-003-01
TRITEST 100/75/25
HUMAN COMPOUNDED DRUG
26436-5527
Hybrid Pharma
2021/2/1 0:00:00
TESTOSTERONE PROPIONATE; TESTOSTERONE CYPIONATE; TESTOSTERONE ENANTHATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL; 100 mg/1 mL; 75 mg/1 mL
26436-5527-1
Cyanocobalamin
HUMAN COMPOUNDED DRUG
26436-5009
Hybrid Pharma
2021/2/1 0:00:00
CYANOCOBALAMIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1000 ug/1 mL
26436-5009-3
Methylcobalamin
HUMAN COMPOUNDED DRUG
26436-5015
Hybrid Pharma
2021/2/1 0:00:00
METHYLCOBALAMIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
26436-5015-3
Magnesium Chloride
HUMAN COMPOUNDED DRUG
26436-5105
Hybrid Pharma
2021/2/1 0:00:00
MAGNESIUM CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 mL
26436-5105-5
Cyanocobalamin Methionine Inositol choline
HUMAN COMPOUNDED DRUG
26436-5030
Hybrid Pharma
2021/2/1 0:00:00
CYANOCOBALAMIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
26436-5030-3
Estriol
HUMAN COMPOUNDED DRUG
26436-5343
Hybrid Pharma
2021/2/1 0:00:00
ESTRIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 mg
26436-5343-1
Azelaic Acid/Ivermectin/Metronidazole/Niacinamide
HUMAN COMPOUNDED DRUG
72627-3178
Empower Pharmacy
2021/2/1 0:00:00
AZELAIC ACID; NIACINAMIDE; METRONIDAZOLE; IVERMECTIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 g; 40 mg/1 g; 10 mg/1 g; 10 mg/1 g
72627-3178-1
Clindamycin/Niacinamide/Tretinoin
HUMAN COMPOUNDED DRUG
72627-3214
Empower Pharmacy
2021/2/1 0:00:00
CLINDAMYCIN PHOSPHATE; NIACINAMIDE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 g; 40 mg/1 g; .5 mg/1 g
72627-3214-1
Hydrocortisone/Hydroquinone/Tretinoin
HUMAN COMPOUNDED DRUG
72627-3157
Empower Pharmacy
2021/2/1 0:00:00
HYDROCORTISONE; HYDROQUINONE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 g; 60 mg/1 g; 1 mg/1 g
72627-3157-1
Ephedrine Sulfate
HUMAN COMPOUNDED DRUG
61141-1374
Medi-Fare Drug
2021/2/1 0:00:00
EPHEDRINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
61141-1374-5
Fentanyl Citrate Drip
HUMAN COMPOUNDED DRUG
61141-1318
Medi-Fare Drug
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 ug/1 mL
61141-1318-1
Fentanyl Citrate, Bupivacaine HCl
HUMAN COMPOUNDED DRUG
61141-4837
Medi-Fare Drug
2021/2/1 0:00:00
BUPIVACAINE HYDROCHLORIDE; FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1.25 mg/1 mL; 2 ug/1 mL
61141-4837-1
Fentanyl Citrate, Bupivacaine HCl
HUMAN COMPOUNDED DRUG
61141-4836
Medi-Fare Drug
2021/2/1 0:00:00
FENTANYL CITRATE; BUPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2 ug/1 mL; 1 mg/1 mL
61141-4836-1
Neostigmine Methylsulfate
HUMAN COMPOUNDED DRUG
61141-1372
Medi-Fare Drug
2021/2/1 0:00:00
NEOSTIGMINE METHYLSULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
61141-1372-5
norepinephrine bitartrate
HUMAN COMPOUNDED DRUG
76154-471
Athenex Pharma Solutions, LLC
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
16 ug/1 mL
76154-471-15
norepinephrine bitartrate
HUMAN COMPOUNDED DRUG
76154-472
Athenex Pharma Solutions, LLC
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
32 ug/1 mL
76154-472-15
norepinephrine bitartrate
HUMAN COMPOUNDED DRUG
76154-473
Athenex Pharma Solutions, LLC
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
64 ug/1 mL
76154-473-15
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3